Pediatric Radiation Therapy Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-26
SponsorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

About this trial

The Johns Hopkins Pediatric Radiation Oncology Program is creating a registry that will capture the full 3D radiation dosimetry delivered to its pediatric patients to manage the quality of care provided, as well as to examine the long-term outcomes and toxicity of each patient. The registry will capture baseline clinical data, disease, toxicity, and quality of life outcomes. The goal is to include all pediatric patients undergoing proton therapy and photon therapy to enable future comparisons of treatment outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Treatment with either proton or photon radiation therapy.

Disqualifiers

Greater than 26 years old

Trial population

Pediatric brain tumor and bone and soft tissue sarcoma patients that are being treated with proton or photon radiation therapy.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

5,000 Participants
are grouped into 3 trial groups
Group A: Pediatric brain tumors
Group B: Pediatric sarcomas
Group C: Non-brain-tumor and non-sarcoma

Trial outcomes

Primary outcomes

1

Overall Survival

Measured from date of diagnosis until death, obtained from medical record notes

Time frame
Approximately 10 years
2

Toxicity due to Radiation Therapy as assessed by number of patients with adverse events

The number of patients that experience adverse events, obtained from medical record notes

Time frame
Approximately 10 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.